Literature DB >> 7251862

Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

G W Hunninghake, J E Gadek, T J Lawley, R G Crystal.   

Abstract

Neutrophils are a characteristic feature of the alveolitis of idiopathic pulmonary fibrosis (IPF). a chronic disorder limited to lung. One mechanism by which neutrophils may be selectively attracted to lung and not other tissues is via the secretion of the neutrophil-specific chemotactic factor by alveolar macrophages. To evaluate the role of alveolar macrophages in modulating the migration of neutrophils to he lung in IPF, alveolar macrophages, obtained by bronchoalveolar lavage of patients with IPF, were evaluated for their ability to release a chemotactic factor for neutrophils. Unstimulated alveolar macrophages from normal individuals did not release the factor. In patients with IPF, there was a significant correlation between the proportions of neutrophils in lavage fluid and the release of a chemotactic factor for neutrophils by alveolar macrophages (p less than 0.001). The chemotactic factor released by IPF alveolar macrophages was of low molecular weight (400-600), at least partially lipid in nature, and preferentially attracted neutrophils compared with monocytes. Several lines of evidence suggested that immune complexes in the lung stimulated alveolar macrophages of patients with IPF to release the chemotactic factor. First, immune complexes stimulated normal macrophages to release the factor.Second, there was a significant correlation between the release of the chemotactic factor by IPF alveolar macrophages and the levels of immune complexes in bronchoalveolar lavage fluid. Third, bronchoalveolar lavage fluid containing immune complexes stimulated normal macrophages to release the factor. Fourth, IPF alveolar macrophages that released large amounts of the chemotactic factor had an apparent suppression of their immunoglobulin (Ig)G Fc receptor function, suggesting that immune complexes were bound to their surface. In contrast, the IgG Fc receptor function of IPF alveolar macrophages that released only small amounts of the factor was similar to that of normal macrophages. These studies suggest that neutrophils are attracted to the lung in patients with IPF by a potent chemotactic factor released by alveolar macrophages that have been stimulated, in vivo, via their IgG Fc receptor by immune complexes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251862      PMCID: PMC370793          DOI: 10.1172/jci110242

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.

Authors:  J I Gallin; R A Clark; M M Frank
Journal:  Clin Immunol Immunopathol       Date:  1975-01

2.  Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities.

Authors:  G W Hunninghake; A S Fauci
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

5.  Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases.

Authors:  E C Lawrence; R R Martin; R M Blaese; R B Teague; R J Awe; R K Wilson; W J Deaton; K Bloom; S D Greenberg; P M Stevens
Journal:  N Engl J Med       Date:  1980-05-22       Impact factor: 91.245

6.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

7.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.

Authors:  R Snyderman; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

9.  Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor.

Authors:  R Snyderman; J Phillips; S E Mergenhagen
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

10.  Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.

Authors:  C J Jaffe; J M Vierling; E A Jones; T J Lawley; M M Frank
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

View more
  54 in total

1.  Interstitial lung disease: aggressive clinical management versus diagnostic and therapeutic nihilism.

Authors:  R G Crystal
Journal:  West J Med       Date:  1982-04

2.  Proportions of resting memory T cells and monocytes in blood have prognostic significance in idiopathic pulmonary fibrosis.

Authors:  Yao-Zhong Liu; Shigeki Saito; Gilbert F Morris; Charles A Miller; Jian Li; John J Lefante
Journal:  Genomics       Date:  2018-09-24       Impact factor: 5.736

3.  The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis.

Authors:  B Noble; R M Du Bois; L W Poulter
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

Review 4.  Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.

Authors:  Eric S White; Michael H Lazar; Victor J Thannickal
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

5.  Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.

Authors:  Mark S Wilson; Satish K Madala; Thirumalai R Ramalingam; Bernadette R Gochuico; Ivan O Rosas; Allen W Cheever; Thomas A Wynn
Journal:  J Exp Med       Date:  2010-02-22       Impact factor: 14.307

6.  Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.

Authors:  P B Bitterman; S I Rennard; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

7.  Role of alveolar macrophages in asbestosis: modulation of neutrophil migration to the lung after acute asbestos exposure.

Authors:  C I Schoenberger; G W Hunninghake; O Kawanami; V J Ferrans; R G Crystal
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

8.  Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines.

Authors:  S Koyama; E Sato; H Nomura; K Kubo; M Miura; T Yamashita; S Nagai; T Izumi
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes.

Authors:  E Kownatzki; A Kapp; S Uhrich
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity.

Authors:  G E de Souza; S H Ferreira
Journal:  Agents Actions       Date:  1985-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.